Minoru Ichikawa

Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event

Carolyn S.P. Lam, Anna Giczewska, Karen Sliwa et al. · JAMA Cardiology · 2020 · 82 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation

Koshiro Kanaoka, Kenji Onoue, Satoshi Terasaki et al. · Circulation · 2022 · 59 citations · Full text

Medicine, Cardiology, Internal Medicine +13

Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells

Li Lan, Tsuyuko Hayashi, Rokshana M. Rabeya et al. · DNA repair · 2003 · 55 citations

Life Sciences, Biochemistry, Molecular Biology +10

Lowering Uric Acid May Improve Prognosis in Patients With Hyperuricemia and Heart Failure With Preserved Ejection Fraction

Masami Nishino, Yasuyuki Egami, Shodai Kawanami et al. · Journal of the American Heart Association · 2022 · 36 citations · Full text

Medicine, Cardiology, Clinical Epidemiology +12

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17